BARD1 and cancer: Over the past years increasing evidence has emphasized the involvement of BARD1 (BRCA1-associated RING domain 1) in the pathogenesis of different cancers, including breast, ovarian, uterine, colon and lung cancer, as well as neuroblastoma [2-6].